ロード中...
Emerging therapeutic options for myelofibrosis: a Canadian perspective
Myelofibrosis (MF) is a clonal stem cell disorder characterized by cytopenias, splenomegaly, marrow fibrosis, and systemic symptoms due to elevated inflammatory cytokines. MF is associated with decreased survival. The quality of life of patients with MF is similar to other advanced malignancies. All...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
e-Century Publishing Corporation
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484412/ https://ncbi.nlm.nih.gov/pubmed/23119228 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|